Company news
Synektik Sa (GPW:SNT) news
Synektik Sa news releases on 6ix. Latest, Jul 6, 2026: Synektik Unit Signs Deal With A Hospital In Kaunas For Delivery Of Da Vinci System
Press releases & updates
Synektik Unit Signs Deal With A Hospital In Kaunas For Delivery Of Da Vinci System
July 6, 2026
Synektik Unit Signs €2.7 Mln Deal For Delivery Of Exablate Neuro MRgFUS Neurosurgery System
June 26, 2026
Ksiazek Holding Sells 16.13% Stake In Synektik At 300 Zlotys/Shr Under ABB
June 17, 2026
Synektik Announces ABB For 1.38 Million Shares, 16.13% Of Share Capital
June 16, 2026
SNT: Record revenue and EBITDA, strong backlog, and rising recurring revenue signal robust growth ahead
June 11, 2026
Synektik Signs Max. 10.1 Mln Zloty Deal For Supply Of Consumables For Da Vinci System
May 19, 2026
Synektik Estimates Non-Cash Gain Of About 261 Mln Zlotys From Syn2bio Spin-Off
May 14, 2026
Synektik Unit Signs EUR 3.7 Mln Deals For Delivery Of Da Vinci System With Hospital In Czech Republic
May 6, 2026
Synektik Estimates H1 Consolidated Revenue At About 441 Million Zlotys
April 23, 2026
Syn2bio shares halted at Warsaw Stock Exchange debut
April 15, 2026
Synektik Secures Orders Worth About 163 Million Zlotys In Q2
April 9, 2026
Synektik Signs 30.0 Mln Zloty Deals For Delivery Of Da Vinci System
March 23, 2026
Synektik Signs 21.2 Mln Zloty Deals With University Clinical Center In Gdansk For Da Vinci 5 System
March 19, 2026
Synektik Says KNF Approves Syn2bio Prospectus For Spin-Off
March 12, 2026
Synektik Signs Deal With Hospital In Grudziadz For Da Vinci System
March 10, 2026
SNT: Double-digit revenue and profit growth, robust recurring income, and strategic expansion initiatives
February 12, 2026
Synektik To Transfer Organized Part Of Enterprise Related To Cardiomarker And CBNC To Syn2bio
February 3, 2026
Synektik Expands And Extends Distribution Agreement With Intuitive Surgical
February 2, 2026
Synektik Signs 18.3 Mln Zloty Deal For Delivery For Da Vinci System
January 28, 2026
Synektik Signs 18.5 Mln Zloty Deal With University Hospital In Szczecin For Delivery Of Da Vinci System
January 22, 2026
Synektik Unit Signs $3.0 Mln Deal For Da Vinci System Delivery With Ostrava City Hospital
January 13, 2026
Synektik Q1 Medical Equipment Orders Value At 148 Mln Zlotys
January 12, 2026
Synektik Signs 13.1 Mln Zlotys Contract With Hospital In Włocławek For Da Vinci Robotic System
January 9, 2026
Synektik Signs Deal For Distribution Of Cancer Therapy Equipment
January 8, 2026
Synektik Signs 20.8 Mln Zloty Deal For Delivery Of Da Vinci System
December 22, 2025
Synektik Completes Order For Da Vinci Robotic Surgery System
December 15, 2025
Synektik Signs Max. 15 Mln Zloty Contracts For Supply Of Consumables For Da Vinci System
December 10, 2025
Synektik Signs Max. 13.8 Mln Zloty Deal For Da Vinci System Supplies
December 5, 2025
Synektik Signs A 15.7 Mln Zloty Deal With State Medical Institute MSWiA For Da Vinci Robotic Surgery System Delivery
December 4, 2025
Synektik Signs 10.9 Million Zloty Net Deal For Delivery Of Da Vinci System With Hospital In Krakow
December 3, 2025
SNT: 9% revenue growth, 24% EBITDA increase, and strategic R&D spin-off highlight strong results
November 18, 2025
Synektik Signs 12.3 Million Zlotys Deal With Provincial Hospital In Bielsko-Biała For Delivery Of Da Vinci System
October 27, 2025
Synektik Signs 16.2 Mln Zlotys Deal For Da Vinci System
October 23, 2025
Synektik Signs 9.3 Mln Zloty Deal With Szpitale Pomorskie For da Vinci System
October 21, 2025
Synektik Signs 15.5 Mln Zlotys Da Vinci System Deal With Hospital In Elbląg
October 20, 2025
Synektik Signs Up To 9.9 Million Zloty Deal For Supply Of Materials For Da Vinci System
October 14, 2025
Synektik Signs 19.1 Mln Zlotys Deal For Da Vinci System
September 29, 2025
SNT: Q3 revenue up 24% YoY, EBITDA up 31%, with R&D spin-off and robust recurring revenue growth
August 7, 2025
SNT: EBITDA margin rose to 24.7% as recurring revenues grew, despite a 9% drop in sales
June 11, 2025
SNT: Recurring revenue and radio-pharmaceutical sales rose, while EBITDA margin improved
February 5, 2025
SNT: Record revenue and EBITDA growth, R&D spin-off, and expanded robotic surgery footprint
November 14, 2024
SNT: Revenue up 55% and net profit up 74% year-over-year, with strong growth in all key segments
August 6, 2024
SNT: Revenue and EBITDA soared on strong medical equipment and recurring sales, with robust outlook
June 11, 2024